Online Program Home
My Program

Legend:
CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

470 Wed, 7/31/2019, 8:30 AM - 10:20 AM CC-108
Biomarker Evaluation and Winning Student Papers on Medical Devices and Diagnostics — Contributed Papers
Section on Medical Devices and Diagnostics
Chair(s): Barbara Wendelberger, Berry Consultants, LLC
8:35 AM Shock Prediction Using Vital Sign Time Series
Iris Bennett, North Carolina State University; Bill Rand, North Carolina State University
8:50 AM Combining Biomarker Trajectories to Improve Diagnostic Accuracy in Prospective Cohort Studies with Verification Bias

Hong Li, Medical University of South Carolina; Constantine Gatsonis, Brown University
9:05 AM Bayesian Hierarchical Models for Voxel-Wise Classification of Prostate Cancer Accounting for Spatial Correlation and Between-Patient Heterogeneity in the Multi-Parametric MRI Data
Jin Jin, Division of Biostatistics, University of Minnesota; Joseph Koopmeiners, University of Minnesota; Lin Zhang, Division of Biostatistics, University of Minnesota; Ethan Leng, Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota; Gregory Metzger, Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota
9:20 AM Smoothed Empirical Likelihood Inference for the Youden Index Subject to Limit of Detection
Dongliang Wang, SUNY Upstate Medical University
9:35 AM Analyzing Wearable Device Data Using Marked Point Processes
Yuchen Yang, Johns Hopkins University; Mei-Cheng Wang, Johns Hopkins University
9:50 AM BayesCT: a Tool for Simulation and Analysis of Adaptive Bayesian Clinical Trials

Thevaa Chandereng, University of Wisconsin-Madison; Donald Musgrave, Medtronic; Tarek Haddad, Medtronic ; Graeme Hickey, Medtronic; Tim Hanson, Medtronic ; Theodore Lystig, Medtronic; Rick Chappell, University of Wisconsin-Madison
10:05 AM Constructed Composite Response: a Framework for Constructing Targeted Latent Variables
Christopher Barbour, National Institutes of Health; Mark Greenwood, Montana State University; Dominique Zosso, Montana State University; Bibiana Bielekova, National Institute of Allergy and Infectious Diseses